Acute parvovirus B19 infection in pregnant women - An analysis of serial samples by serological and semi-quantitative PCR techniques

被引:22
作者
Searle, K [1 ]
Guilliard, C [1 ]
Wallat, S [1 ]
Schalasta, G [1 ]
Enders, G [1 ]
机构
[1] Epidemiol & Infektiol EV, Inst Virol, Inst Virol, D-70193 Stuttgart, Germany
关键词
D O I
10.1007/BF02771838
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The serological and virological course of parvovirus B19 infection was followed in 14 women who suffered symptomatic or subclinical acute infection during pregnancy. Serial serum samples from the patients were tested for IgG and IgM antibodies and the levels of parvovirus B19 DNA were monitored using a semi-quantitative PCR assay. In addition, the outcome of the pregnancies was documented by clinical information and by testing cord blood for parvovirus B19 specific antibodies as well as for parvovirus B19 DNA by PCR. Levels of IgG antibodies rose steadily within 2 months of infection and in some cases began to decline at the end of pregnancy, IgM antibodies were usually detected for at least 2 months and persisted for as long as 9 months in one case. Viral DNA was detectable for at least 8 weeks following infection and semi-quantitative analysis revealed a gradual reduction in virus load during the viraemic phase of infection. There were no apparent differences in the course of antibody development and duration of viraemia in symptomatic versus subclinical infections.
引用
收藏
页码:139 / 143
页数:5
相关论文
共 18 条
[1]  
ANDERSON MJ, 1983, LANCET, V1, P1378
[2]   CANDIDATE RECOMBINANT VACCINE FOR HUMAN B19-PARVOVIRUS [J].
BANSAL, GP ;
HATFIELD, JA ;
DUNN, FE ;
KRAMER, AA ;
BRADY, F ;
RIGGIN, CH ;
COLLETT, MS ;
YOSHIMOTO, K ;
KAJIGAYA, S ;
YOUNG, NS .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) :1034-1044
[3]   POLYMERASE CHAIN-REACTION ASSAY OF PARVOVIRUS B19 DNA IN CLINICAL SPECIMENS [J].
CLEWLEY, JP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2647-2651
[4]   FORTNIGHTLY REVIEW - PARVOVIRUS B19 - AN EXPANDING SPECTRUM OF DISEASE [J].
COHEN, B .
BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7019) :1549-1552
[5]   PARVOVIRUS B19 INFECTION IN-HOSPITAL WORKERS - COMMUNITY OR HOSPITAL ACQUISITION [J].
DOWELL, SF ;
TOROK, TJ ;
THORP, JA ;
HEDRICK, J ;
ERDMAN, DD ;
ZAKI, SR ;
HINKLE, CJ ;
BAYER, WL ;
ANDERSON, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04) :1076-1079
[6]   Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy:: Two case reports [J].
Enders, G ;
Dötsch, J ;
Bauer, J ;
Nützenadel, W ;
Hengel, H ;
Haffner, D ;
Schalasta, G ;
Searle, K ;
Brown, KE .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) :355-358
[7]  
ENDERS G, 1998, TOPLEY WILSONS MICRO, P873
[8]   THE INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION DURING PREGNANCY AND ITS IMPACT ON PERINATAL OUTCOME [J].
GRATACOS, E ;
TORRES, PJ ;
VIDAL, J ;
ANTOLIN, E ;
COSTA, J ;
DEANTA, MTJ ;
CARARACH, V ;
ALONSO, PL ;
FORTUNY, A .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1360-1363
[9]  
HALL SM, 1990, BMJ-BRIT MED J, V300, P1166
[10]  
Komischke K, 1997, PRENATAL DIAG, V17, P1039, DOI 10.1002/(SICI)1097-0223(199711)17:11<1039::AID-PD191>3.3.CO